Edward Nirenberg on Nostr: 2. There is consensus that a Phase 3 field efficacy study for pertussis is not ...
2. There is consensus that a Phase 3 field efficacy study for pertussis is not presently feasible given the circumstances of its epidemiology. However, CHIM studies are necessarily smaller and consequently there would be a lack of data to inform on safety, i.e. rare risks, of vaccination.
4/5
Published at
2024-09-20 17:10:18Event JSON
{
"id": "7f836d5611b5ab75e9492a203695a7c055b466a948b18ffb7761880d03dd1f1d",
"pubkey": "c67b38e4c5023e985f04ae7ab6a6669cf463220e1b9ed54b897d1957004603a4",
"created_at": 1726852218,
"kind": 1,
"tags": [
[
"e",
"fc9bb0b7218da75ea71fac4bb1179d2d3132e4669926d6bc54e5df12c846365a",
"wss://relay.mostr.pub",
"reply"
],
[
"proxy",
"https://med-mastodon.com/users/enirenberg/statuses/113170987006463799",
"activitypub"
]
],
"content": "2. There is consensus that a Phase 3 field efficacy study for pertussis is not presently feasible given the circumstances of its epidemiology. However, CHIM studies are necessarily smaller and consequently there would be a lack of data to inform on safety, i.e. rare risks, of vaccination.\n4/5",
"sig": "23f8c240423c750e062b268cdd06e5632502bc12bc1930863115cb821ecb895c6909bc4debf05012d6c1981365dfa40c77bcb556ac2ce7876df1c1666deda962"
}
